Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?

J Clin Endocrinol Metab. 2003 Feb;88(2):528-30. doi: 10.1210/jc.2002-021971.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glyburide / adverse effects*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Ischemic Preconditioning*
  • Sulfonylurea Compounds / adverse effects*

Substances

  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Glyburide